What are the roadblocks that are hindering the Oncolytic Viruses Treatment Market?
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjGeMUqKZ3OB_DjxWMQdh_gQpNmGu8ar8AdOBxujOOIRw9RJlE3aA4yy6rbh18z46SPHl9VtfL5sk42GCFgFBjAKlxccrp_B7rqVg4-rSS6KGhq9tuT89uXjh-GFmvpjJChsxuh19h8gn0xDitFPU-d5UcR7LjbP8TJ25GU5kdq4enkn4UyxnbaJkXB/s320/oncolytic-viruses-for-cancer-treatment.png)
What is Oncolytic Virus Therapy? Oncolytic viruses (OVs) are a class of anti-cancer agent that aids in the regression of tumors by reproducing preferentially in tumor cells, causing immunogenic cell death, and enhancing host defenses against tumors. It uses both natural and modified viruses to find and kill malignant cells. Oncolytic viruses are cancer therapies that involve a naturally occurring or reprogrammed virus that can find and kill cancerous cells. They belong to a brand-new family of cancer medicines that promote host antitumor immunity, cause immunogenic cell death, and cause tumor cells to replicate preferentially. Oncolytic viruses are experimental cancer treatments that make advantage of the inherent characteristics of viruses to combat cancer. These non-human viruses disregard healthy cells and thrive only in cancerous ones. Vectors Used in Oncolytic Virotherapy Many DNA and RNA viruses have the potential to act as oncolytic agents, with DNA viruses predominating in c